Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate to Severe Atopic Eczema”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03703102
What this trial is testing

Study of an Anti-OX40 Monoclonal Antibody (KHK4083) in Subjects With Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Kyowa Kirin, Inc. 274
Testing effectiveness (Phase 2)UnknownNCT05186922
What this trial is testing

The Study of CM326 in Patients With Moderate-to-severe Atopic Dermatitis

Who this might be right for
Moderate-to-severe Atopic Dermatitis
Keymed Biosciences Co.Ltd 54
Testing effectiveness (Phase 2)Study completedNCT02864498
What this trial is testing

Efficacy and Safety Study of Orally Administered DS107 in Moderate to Severe Atopic Dermatitis Patients

Who this might be right for
Atopic Dermatitis
DS Biopharma 321
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07344051
What this trial is testing

A Phase II Study of QLS12010 Capsules in Adults With Moderate to Severe Atopic Dermatitis

Who this might be right for
Moderate-to-severe Atopic Dermatitis
Qilu Pharmaceutical Co., Ltd. 160
Testing effectiveness (Phase 2)Study completedNCT04365387
What this trial is testing

Assess Immunization Responses in Adult and Adolescent Participants With Moderate-to-Severe Atopic Dermatitis Treated With Nemolizumab

Who this might be right for
Dermatitis, Atopic
Galderma R&D 242
Not applicableStudy completedNCT06353087
What this trial is testing

Abrocitinib Taiwan Treatment Pattern and Real World Study in ATopiC Dermatitis (ATTRACT Registry)

Who this might be right for
Dermatitis, AtopicDermatitisEczema+3 more
Pfizer 41
Testing effectiveness (Phase 2)Study completedNCT01548404
What this trial is testing

Study of Dupilumab in Adult Patients With Extrinsic Moderate-to-Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Regeneron Pharmaceuticals 109
Testing effectiveness (Phase 2)Study completedNCT05549947
What this trial is testing

Efficacy and Safety Study of SHR-1819 Injection in Adult Patients With Severe Atopic Dermatitis

Who this might be right for
Moderate to Severe Atopic Dermatitis
Shanghai Hengrui Pharmaceutical Co., Ltd. 158
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07502222
What this trial is testing

Evaluate the Efficacy and Safety of AK139 in Patients With Moderate-to-severe Atopic Dermatitis

Who this might be right for
Moderate-to-Severe Atopic Dermatitis
Akeso 168
Early research (Phase 1)Looking for participantsNCT07604324
What this trial is testing

A First-in-human Study to Investigate Single Doses of DCY636 in Healthy Volunteers and Multiple Doses in Participants With Moderate to Severe Atopic Dermatitis

Who this might be right for
Dermatitis, Atopic
Novartis Pharmaceuticals 63
Large-scale testing (Phase 3)Enrolling By InvitationNCT07180511
What this trial is testing

A Phase III Clinical Study of QY201 Tablet in Subjects With Moderate to Severe Atopic Dermatitis.

Who this might be right for
Atopic Dermatitis (AD)
E-nitiate Biopharmaceuticals (Hangzhou) Co., Ltd. 460
Testing effectiveness (Phase 2)Study completedNCT05277571
What this trial is testing

A Single-ascending Dose (Part A) and Repeat-dose (Part B) Study to Investigate the Safety, Pharmacokinetics and Efficacy (Part B Only) of UCB1381 in Healthy Study Participants (Part A) and in Study Participants With Moderate to Severe Atopic Dermatitis (Part B)

Who this might be right for
Atopic Dermatitis
UCB Biopharma SRL 109
Large-scale testing (Phase 3)Looking for participantsNCT06239311
What this trial is testing

Efficacy and Safety of Methotrexate Versus Placebo in Adults With Atopic Dermatitis.

Who this might be right for
Moderate to Severe Atopic Dermatitis
medac GmbH 277
Not applicableStudy completedNCT05451316
What this trial is testing

Assess Change in Disease Activity in Adolescents and Adults With Moderate to Severe Prurigo-type Atopic Dermatitis in Japan Who Are Treated With Oral Upadacitinib

Who this might be right for
Atopic Dermatitis
AbbVie 1
Large-scale testing (Phase 3)Not Yet RecruitingNCT06767540
What this trial is testing

A Clinical Study of AK120 in Adolescents With Moderate-to-severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Akeso 198
Testing effectiveness (Phase 2)Study completedNCT01639040
What this trial is testing

Study to Assess the Safety of Dupilumab (REGN668/SAR231893) Administered Concomitantly With Topical Corticosteroids (TCS) in Patients With Moderate-to-severe Atopic Dermatitis (AD)

Who this might be right for
Atopic Dermatitis
Regeneron Pharmaceuticals 31
Post-approval studies (Phase 4)Study completedNCT04447417
What this trial is testing

Dupilumab Skin Barrier Function Study in Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Sanofi 52
Testing effectiveness (Phase 2)Study completedNCT05375955
What this trial is testing

Learn About The Study Medicine (PF-07038124) In Patients With Mild To Moderate Atopic Dermatitis Or Mild To Severe Plaque Psoriasis.

Who this might be right for
Atopic DermatitisPlaque Psoriasis
Pfizer 263
Testing effectiveness (Phase 2)UnknownNCT04725136
What this trial is testing

Safety and Explore the Efficacy of Multiple Doses of FURESTEM-AD Inj. for Moderate to Severe Chronic Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Kang Stem Biotech Co., Ltd. 96
Large-scale testing (Phase 3)Study completedNCT04146363
What this trial is testing

Evaluation of the Efficacy and Safety of Lebrikizumab (LY3650150) in Moderate to Severe Atopic Dermatitis (ADvocate1)

Who this might be right for
Atopic Dermatitis
Eli Lilly and Company 424
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation